Mancuso C, Pistritto G, Tringali G, Grossman A B, Preziosi P, Navarra P
Institute of Pharmacology, Catholic University Medical School, Rome, Italy.
Brain Res Mol Brain Res. 1997 May;45(2):294-300. doi: 10.1016/s0169-328x(96)00258-6.
Carbon monoxide (CO) shares with nitric oxide (NO) the ability to modulate the release of hypophysiotropic peptides from rat hypothalamic explants. While both gases are believed to act as neural messengers in the brain via the activation of soluble guanylyl cyclase, the latter is almost undetectable in the rat hypothalamus. NO has been shown to exert some of its biological actions through the modulation of prostaglandin endoperoxide synthase (PGHS) activity. We have, therefore, investigated whether CO also can use PGHS as a signaling pathway in the hypothalamus. Endogenous CO is produced in equimolar amounts with biliverdin (BV) by the catabolism of hemin through heme oxygenase (HO). Hemin, two inhibitors of HO, zinc-protoporphyrin-9 (ZnPP9) and tin-mesoporphyrin-9 (SnMP9), ferrous hemoglobin (Hb), indomethacin and dexamethasone (DEX) were used as pharmacological tools. Prostaglandin E2 (PGE2) released from rat hypothalamic explants or primary cultures of hypothalamic astrocytes was taken as a marker of PGHS activity. It was found that: (1) hemin evokes an increase in PGE2 release from hypothalamic explants; (2) this effect is counteracted by ZnPP9, SnMP9, Hb and indomethacin; (3) the metallo-porphyrins and indomethacin, but not Hb, are also able to inhibit basal PGE2 release from hypothalamic explants; and (4) dexamethasone does not inhibit, and even potentiates, the stimulatory effect of hemin on PGE2 release from hypothalamic astrocytes. The evidence presented here suggests that the catabolism of endogenous or exogenously added hemin is associated with an increase in PGE2 production in the rat hypothalamus. This effect can be attributed to the formation of CO, since the other end-product of HO, BV, does not enhance PGE2 release. Thus, at least some of the biological effects of CO at the hypothalamic level might be mediated by the activation of the PGHS pathway.
一氧化碳(CO)与一氧化氮(NO)一样,具有调节大鼠下丘脑外植体中促垂体激素释放的能力。虽然这两种气体都被认为通过激活可溶性鸟苷酸环化酶在大脑中充当神经信使,但后者在大鼠下丘脑中几乎检测不到。已证明NO通过调节前列腺素内过氧化物合酶(PGHS)的活性发挥其一些生物学作用。因此,我们研究了CO是否也能在下丘脑中利用PGHS作为信号通路。内源性CO通过血红素加氧酶(HO)对血红素的分解代谢与胆绿素(BV)等摩尔量产生。血红素、HO的两种抑制剂锌原卟啉-9(ZnPP9)和锡中卟啉-9(SnMP9)、亚铁血红蛋白(Hb)、吲哚美辛和地塞米松(DEX)用作药理学工具。从大鼠下丘脑外植体或下丘脑星形胶质细胞原代培养物中释放的前列腺素E2(PGE2)被用作PGHS活性的标志物。结果发现:(1)血红素引起下丘脑外植体中PGE2释放增加;(2)ZnPP9、SnMP9、Hb和吲哚美辛可抵消这种作用;(3)金属卟啉和吲哚美辛,但不是Hb,也能够抑制下丘脑外植体中基础PGE2的释放;(4)地塞米松不抑制,甚至增强血红素对下丘脑星形胶质细胞中PGE2释放的刺激作用。此处提供的证据表明,内源性或外源性添加的血红素的分解代谢与大鼠下丘脑中PGE2产生的增加有关。这种作用可归因于CO的形成,因为HO的另一种终产物BV不会增强PGE2的释放。因此,CO在下丘脑水平的至少一些生物学作用可能是由PGHS途径的激活介导的。